Retatrutide — Vendor Comparison

A triple agonist targeting GIP, GLP-1, and glucagon receptors. Among the most promising next-generation weight loss peptides in clinical development.

Rankings based on our Vendor Transparency Score — COA publishing, lab accreditation, batch traceability, and published policies.See our methodology →

We earn commissions from some vendors below. This doesn't affect our rankings — they're determined by Vendor Transparency Scores alone.Full disclosure →

How We Score Transparency

COAs PublishedHigh weightCertificates of Analysis visible on site with batch-specific results

Lab AccreditationHigh weightTesting lab is real, accredited, and independently verifiable

Batch TraceabilityHigh weightCOA batch numbers match product listings and packaging

Years in BusinessMedium weightWHOIS + incorporation records confirm operating history

Customer ResponseMedium weightResponds to inquiries within reasonable timeframe

Refund PolicyLow weightPublished refund/remake policy is accessible and clear

Methodology v2.1 · Last updated Mar 12, 2026Full methodology →

Comparison data coming soon

We're actively researching vendors for Retatrutide. Full comparison tables with Vendor Transparency Scores will be available shortly.